معرفی
Jean-Sébastien Fallu is an Associate Professor at the School of Psychoeducation, part of the Faculty of Arts and Science at the Université de Montréal. He holds a PhD in Psychology from the same institution and completed a postdoctoral fellowship at the Centre for Addiction and Mental Health (CAMH) in Toronto. His research focuses on the etiology and prevention of problematic substance use, public health policies, and cannabis-related issues. Dr. Fallu is a regular contributor to media discussions on drug policy and addiction science, with over 800 media interviews. He is affiliated with the Institut universitaire sur les dépendances (IUD), the Centre de recherche en santé publique (CReSP), and the Groupe de Recherche et intervention sur les substances psychoactives du Québec (RISQ). He currently serves as the director of the journal Drogues, santé et société (DSS) and is involved in several research projects funded by the Fonds de recherche du Québec (FRQ) and the Canadian Institutes of Health Research (CIHR).
- Education: PhD in Psychology (Université de Montréal), Postdoctoral Fellowship (CAMH, Toronto)
- Research Interests: Adolescent substance use, cannabis policy, harm reduction, prevention strategies, public health policies
- Awards: Forces Avenir 2002 Award for Société, communication et éducation
- Affiliations: CIUSSS du Centre-Sud-de-l’Île-de-Montréal, IUD, CReSP, RISQ
His research has led to over 30 publications and 60 scientific presentations. He supervises graduate students in Master's and PhD programs, focusing on topics such as cannabis use among youth, alcohol consumption during the pandemic, and the impact of policy interventions. He has led projects on substance use prevention, evaluating the efficacy of school transition programs and harm reduction strategies.
Dr. Fallu’s current grants include initiatives on opioid interventions, psilocybin therapy in palliative care, and the role of cannabis use onset in substance use disorders. His work bridges academic research with community outreach, emphasizing evidence-based policy and reducing stigma around substance use.
